Catalyst Wire Dossier Catalyst Wire Dossier

Vilobelimab

vilobelimab · InflaRx N.V.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vilobelimab, covering 2016-04-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab [Phase 2]

See pricing